These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11266422)

  • 21. Molecular cloning and nucleotide sequence of a new plasmid-coded Klebsiella pneumoniae beta-lactamase gene (SHV-2a) responsible for high-level cefotaxime resistance.
    Podbielski A; Schönling J; Melzer B; Warnatz K
    Zentralbl Bakteriol; 1991 Aug; 275(3):369-73. PubMed ID: 1741919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel transferable extended-spectrum beta-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidime.
    Arlet G; Rouveau M; Bengoufa D; Nicolas MH; Philippon A
    FEMS Microbiol Lett; 1991 Jun; 65(1):57-62. PubMed ID: 1874404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.
    Bradford PA; Cherubin CE; Idemyor V; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1994 Apr; 38(4):761-6. PubMed ID: 8031043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea.
    Kim J; Kwon Y; Pai H; Kim JW; Cho DT
    J Clin Microbiol; 1998 May; 36(5):1446-9. PubMed ID: 9574728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.
    Rice LB; Carias LL; Hujer AM; Bonafede M; Hutton R; Hoyen C; Bonomo RA
    Antimicrob Agents Chemother; 2000 Feb; 44(2):362-7. PubMed ID: 10639363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
    Steward CD; Rasheed JK; Hubert SK; Biddle JW; Raney PM; Anderson GJ; Williams PP; Brittain KL; Oliver A; McGowan JE; Tenover FC
    J Clin Microbiol; 2001 Aug; 39(8):2864-72. PubMed ID: 11474005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26.
    Chang FY; Siu LK; Fung CP; Huang MH; Ho M
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2407-13. PubMed ID: 11502506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy.
    Marchese A; Arlet G; Schito GC; Lagrange PH; Philippon A
    Eur J Clin Microbiol Infect Dis; 1996 Mar; 15(3):245-8. PubMed ID: 8740862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri.
    Yang Y; Bhachech N; Bradford PA; Jett BD; Sahm DF; Bush K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1671-6. PubMed ID: 9661002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfer of antibiotic resistance and production of extended-spectrum beta-lactamase (ESBL) in nosocomial Klebsiella pneumoniae strains from two hospitals in Czech Republic.
    Blahová J; Králiková K; Krcméry V; Torsová V
    Zentralbl Bakteriol; 1997 Nov; 286(4):449-55. PubMed ID: 9440193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of bla(CTX-M) extended spectrum beta-lactamase genes in Klebsiella pneumoniae isolates from a tertiary care hospital: first report of bla(SHV-12), bla(SHV-31), bla(SHV-38), and bla(CTX-M-15) in Brazil.
    Tollentino FM; Polotto M; Nogueira ML; Lincopan N; Neves P; Mamizuka EM; Remeli GA; De Almeida MT; Rúbio FG; Nogueira MC
    Microb Drug Resist; 2011 Mar; 17(1):7-16. PubMed ID: 20795871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran.
    Feizabadi MM; Delfani S; Raji N; Majnooni A; Aligholi M; Shahcheraghi F; Parvin M; Yadegarinia D
    Microb Drug Resist; 2010 Mar; 16(1):49-53. PubMed ID: 19961397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of extended-spectrum beta-lactamases from Klebsiella pneumoniae strains isolated in Zagreb, Croatia.
    Bedenić B; Randegger CC; Stobberingh E; Hächler H
    Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):505-8. PubMed ID: 11561810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
    Jang W; Park YJ; Park KG; Yu J
    J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SHV-14, a novel beta-lactamase variant in Klebsiella pneumoniae isolates from Nijmegen, The Netherlands.
    Yuan M; Hall LM; Hoogkamp-Korstanje J; Livermore DM
    Antimicrob Agents Chemother; 2001 Jan; 45(1):309-11. PubMed ID: 11120985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of SHV β-lactamase variants in resistance of clinical Klebsiella pneumoniae strains to β-lactams in an Algerian hospital.
    Ramdani-Bouguessa N; Manageiro V; Jones-Dias D; Ferreira E; Tazir M; Caniça M
    J Med Microbiol; 2011 Jul; 60(Pt 7):983-987. PubMed ID: 21415202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa.
    Essack SY; Hall LM; Pillay DG; McFadyen ML; Livermore DM
    Antimicrob Agents Chemother; 2001 Jan; 45(1):88-95. PubMed ID: 11120950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.
    Bradford PA; Urban C; Jaiswal A; Mariano N; Rasmussen BA; Projan SJ; Rahal JJ; Bush K
    Antimicrob Agents Chemother; 1995 Apr; 39(4):899-905. PubMed ID: 7785992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.